BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 25728766)

  • 1. Skp2-dependent ubiquitination and activation of LKB1 is essential for cancer cell survival under energy stress.
    Lee SW; Li CF; Jin G; Cai Z; Han F; Chan CH; Yang WL; Li BK; Rezaeian AH; Li HY; Huang HY; Lin HK
    Mol Cell; 2015 Mar; 57(6):1022-1033. PubMed ID: 25728766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade.
    Hawley SA; Boudeau J; Reid JL; Mustard KJ; Udd L; Mäkelä TP; Alessi DR; Hardie DG
    J Biol; 2003; 2(4):28. PubMed ID: 14511394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AhR activation promotes Treg cell generation by enhancing Lkb1-mediated fatty acid oxidation via the Skp2/K63-ubiquitination pathway.
    Zhang Q; Zhu Y; Lv C; Fang Y; Liao M; Xia Y; Wei Z; Dai Y
    Immunology; 2023 Aug; 169(4):412-430. PubMed ID: 36930164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 3-phosphoglycerate and other metabolites on the activation of AMP-activated protein kinase by LKB1-STRAD-MO25.
    Ellingson WJ; Chesser DG; Winder WW
    Am J Physiol Endocrinol Metab; 2007 Feb; 292(2):E400-7. PubMed ID: 16985256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the LKB1-STRAD-MO25 complex.
    Boudeau J; Scott JW; Resta N; Deak M; Kieloch A; Komander D; Hardie DG; Prescott AR; van Aalten DM; Alessi DR
    J Cell Sci; 2004 Dec; 117(Pt 26):6365-75. PubMed ID: 15561763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of LKB1/STRAD localization and function by E-cadherin.
    Sebbagh M; Santoni MJ; Hall B; Borg JP; Schwartz MA
    Curr Biol; 2009 Jan; 19(1):37-42. PubMed ID: 19110428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tankyrase disrupts metabolic homeostasis and promotes tumorigenesis by inhibiting LKB1-AMPK signalling.
    Li N; Wang Y; Neri S; Zhen Y; Fong LWR; Qiao Y; Li X; Chen Z; Stephan C; Deng W; Ye R; Jiang W; Zhang S; Yu Y; Hung MC; Chen J; Lin SH
    Nat Commun; 2019 Sep; 10(1):4363. PubMed ID: 31554794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells.
    Wang ST; Ho HJ; Lin JT; Shieh JJ; Wu CY
    Cell Death Dis; 2017 Feb; 8(2):e2626. PubMed ID: 28230855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skp2-Mediated Stabilization of MTH1 Promotes Survival of Melanoma Cells upon Oxidative Stress.
    Wang JY; Liu GZ; Wilmott JS; La T; Feng YC; Yari H; Yan XG; Thorne RF; Scolyer RA; Zhang XD; Jin L
    Cancer Res; 2017 Nov; 77(22):6226-6239. PubMed ID: 28947420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of the LKB1-STRAD-MO25 complex reveals an allosteric mechanism of kinase activation.
    Zeqiraj E; Filippi BM; Deak M; Alessi DR; van Aalten DM
    Science; 2009 Dec; 326(5960):1707-11. PubMed ID: 19892943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SKP2 Promotes Hepatocellular Carcinoma Progression Through Nuclear AMPK-SKP2-CARM1 Signaling Transcriptionally Regulating Nutrient-Deprived Autophagy Induction.
    Wei X; Li X; Yan W; Zhang X; Sun Y; Zhang F
    Cell Physiol Biochem; 2018; 47(6):2484-2497. PubMed ID: 29991055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Skp2 Pathway: A Critical Target for Cancer Therapy.
    Cai Z; Moten A; Peng D; Hsu CC; Pan BS; Manne R; Li HY; Lin HK
    Semin Cancer Biol; 2020 Dec; 67(Pt 2):16-33. PubMed ID: 32014608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SKP2- and OTUD1-regulated non-proteolytic ubiquitination of YAP promotes YAP nuclear localization and activity.
    Yao F; Zhou Z; Kim J; Hang Q; Xiao Z; Ton BN; Chang L; Liu N; Zeng L; Wang W; Wang Y; Zhang P; Hu X; Su X; Liang H; Sun Y; Ma L
    Nat Commun; 2018 Jun; 9(1):2269. PubMed ID: 29891922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis.
    Calvisi DF; Ladu S; Pinna F; Frau M; Tomasi ML; Sini M; Simile MM; Bonelli P; Muroni MR; Seddaiu MA; Lim DS; Feo F; Pascale RM
    Gastroenterology; 2009 Nov; 137(5):1816-26.e1-10. PubMed ID: 19686743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATP and MO25alpha regulate the conformational state of the STRADalpha pseudokinase and activation of the LKB1 tumour suppressor.
    Zeqiraj E; Filippi BM; Goldie S; Navratilova I; Boudeau J; Deak M; Alessi DR; van Aalten DM
    PLoS Biol; 2009 Jun; 7(6):e1000126. PubMed ID: 19513107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SUMOylation regulates LKB1 localization and its oncogenic activity in liver cancer.
    Zubiete-Franco I; García-Rodríguez JL; Lopitz-Otsoa F; Serrano-Macia M; Simon J; Fernández-Tussy P; Barbier-Torres L; Fernández-Ramos D; Gutiérrez-de-Juan V; López de Davalillo S; Carlevaris O; Beguiristain Gómez A; Villa E; Calvisi D; Martín C; Berra E; Aspichueta P; Beraza N; Varela-Rey M; Ávila M; Rodríguez MS; Mato JM; Díaz-Moreno I; Díaz-Quintana A; Delgado TC; Martínez-Chantar ML
    EBioMedicine; 2019 Feb; 40():406-421. PubMed ID: 30594553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RBM4 dictates ESCC cell fate switch from cellular senescence to glutamine-addiction survival through inhibiting LKB1-AMPK-axis.
    Chen L; Zhang W; Chen D; Yang Q; Sun S; Dai Z; Li Z; Liang X; Chen C; Jiao Y; Zhi L; Zhao L; Zhang J; Liu X; Zhao J; Li M; Wang Y; Qi Y
    Signal Transduct Target Ther; 2023 Apr; 8(1):159. PubMed ID: 37080995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the liver kinase B1-mouse protein-25 -Ste-20-related adaptor protein complex in adult mouse skeletal muscle.
    Smith CD; Compton RA; Bowler JS; Kemp JT; Sudweeks SN; Thomson DM; Winder WW
    J Appl Physiol (1985); 2011 Dec; 111(6):1622-8. PubMed ID: 21903876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-chain acyl-CoA esters inhibit phosphorylation of AMP-activated protein kinase at threonine-172 by LKB1/STRAD/MO25.
    Taylor EB; Ellingson WJ; Lamb JD; Chesser DG; Winder WW
    Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1055-61. PubMed ID: 15644453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of liver kinase B1 predicts poor prognosis in hepatocellular carcinoma.
    Tan X; Liao Z; Liang H; Chen X; Zhang B; Chu L
    Int J Oncol; 2018 Nov; 53(5):1913-1926. PubMed ID: 30226588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.